Physician

Olatubosun Fashoro, MD

According to 2025 Medicare claims, Olatubosun Fashoro, MD (NPI: 1700823598) practices internal medicine in the Grand Forks, ND-MN market, with the plurality of this provider's patient population coming from Polk, MN. This provider's primary affiliated billing organization is RIVERVIEW HEALTHCARE ASSOCIATION (NPI: 1487944898; TIN: 410724029) and primary practice location at 56716-1601. Fashoro is affiliated with the Essentia Health ACO, Inc. (ACO ID: A5617) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Fashoro's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 114 traditional Medicare patients, billed 199 HCPCS/CPT codes, and received $11,631 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 12,245 prescription claims across 535 beneficiaries totaling $1,081,758 in drug costs, led by Ozempic (Semaglutide). DME data shows 559 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $17,479 and ending at $11,631. Concurrently, Part D prescription costs have changed little. For DME billing, reported payments did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	92	293	$17,479
2016	185	522	$24,776
2017	178	478	$15,953
2018	187	443	$20,527
2019	156	392	$21,146
2020	297	978	$49,195
2021	187	400	$20,724
2022	197	401	$21,025
2023	121	230	$13,283
2024	114	199	$11,631

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	406	11,954	$913,177
2016	418	12,555	$1,020,539
2017	440	11,728	$920,224
2018	451	12,106	$980,041
2019	442	11,907	$981,409
2020	434	12,223	$1,044,694
2021	488	11,676	$1,060,110
2022	507	11,497	$1,154,028
2023	498	10,814	$1,216,470
2024	535	12,245	$1,081,758

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	91	412	$19,513
2016	106	589	$32,072
2017	91	505	$24,124
2018	107	509	$23,391
2019	241	973	$41,258
2020	154	692	$25,985
2021	171	664	$18,012
2022	204	682	$23,185
2023	199	607	$20,387
2024	154	559	$17,518

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	15	16	$95
90662	Influenza vaccine split virus, preservative free	51	52	$81
99238	Hospital discharge day management, 30 minutes or less	26	30	$63
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	12	22	$38
93005	Routine electrocardiogram (ecg) using at least 12 leads with tracing	28	34	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	224	8,428	$276,809
Eliquis	Apixaban	99	4,359	$84,659
Janumet	Sitagliptin Phos/Metformin Hcl	75	4,240	$72,996
Tresiba Flextouch U-200	Insulin Degludec	26	1,379	$47,457
Xarelto	Rivaroxaban	71	2,370	$43,948

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7031	Face mask interface, replacement for full face mask, each	N	N/R	34	$2,667
A7030	Full face mask used with positive airway pressure device, each	N	N/R	30	$2,443
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	61	$1,937
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	20	28	$1,541
E0470	Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)	Y	N/R	22	$1,534

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Olatubosun Fashoro, MD?

Tedicare shows public-source Medicare data for Olatubosun Fashoro, MD (NPI 1700823598), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Olatubosun Fashoro, MD have ACO affiliation data?

Olatubosun Fashoro, MD is shown with ACO affiliation data for Essentia Health ACO, Inc. (MSSP, ACO ID A5617) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Olatubosun Fashoro, MD?

Olatubosun Fashoro, MD is linked to RIVERVIEW HEALTHCARE ASSOCIATION (billing NPI 1487944898) in the available physician profile data.

Does Olatubosun Fashoro, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.